Novo Nordisk Foundation to Build $62M Quantum Chip Plant in Copenhagen
The Novo Nordisk Foundation is constructing a state-of-the-art quantum chip fabrication facility in Copenhagen, Denmark, set to open in 2027. The 5,300-square-meter facility, known as Quantum Foundry Copenhagen, will offer wafer fabrication services to quantum companies worldwide, addressing a significant manufacturing gap in Europe.
Key Points:
- Investment: The project is backed by an estimated $62 million (according to Bloomberg) investment.
- Focus: The facility will specialize in nanofabrication, characterisation, testing, assembly, packaging, and ultra-high-vacuum manufacturing of quantum materials.
- Goal: To become a leading quantum chip manufacturer, supplying Europe with advanced quantum computing processors and enabling the growth of the quantum industry.
- Funding: The foundation, the charitable owner of Novo Nordisk (known for Ozempic), has committed over €390 million to quantum technologies through research and manufacturing.
- Strategic Move: The project aligns with the European Commission’s focus on strengthening European capacity for quantum chip development and manufacturing, as outlined in the Quantum Europe Strategy and Quantum Act.
Quotes:
“Our vision is to become a world-leading quantum chip manufacturer… enabling quantum companies to scale production.” – Peter Krogstrup, CEO of Quantum Foundry Copenhagen.
“At the Novo Nordisk Foundation, we believe quantum technologies will be one of the most defining scientific and technological fields of this century…” – Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation.
This initiative underscores Denmark’s and Europe’s growing ambition in the quantum realm, aiming to establish a prominent position in the global quantum ecosystem.